CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2026 Financial Results
ZUG, Switzerland and BOSTON, Aug. 03, 2026 ( GLOBE NEWSWIRE ) -- CRISPR Therapeutics ( Nasdaq: CRSP ) today reported financial results for the second quarter ended June 30, 2026.
Why it matters
Attributed market update with source link for portfolio context.